University of Tasmania
Browse
151455 - Global perspectives on immunization against SARS-CoV-2 during pregnancy and priorities for future research.pdf (359.92 kB)

Global perspectives on immunization against SARS-CoV-2 during pregnancy and priorities for future research: an international consensus paper from the World Association of Infectious Diseases and Immunological Disorders

Download (359.92 kB)
journal contribution
posted on 2023-05-21, 10:07 authored by Abu-Raya, B, Madhi, SA, Omer, SB, Amirthalingam, G, Giles, ML, Katie FlanaganKatie Flanagan, Zimmermann, P, O'Ryan, M, Safadi, MA, Papaevangelou, V, Maertens, K, Wanlapakorn, N, Diaz-Brito, V, Tommelein, E, Esposito, S
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.

History

Publication title

Frontiers in Immunology

Volume

12

Article number

808064

Number

808064

ISSN

1664-3224

Department/School

Tasmanian School of Medicine

Publisher

Frontiers Research Foundation

Place of publication

Switzerland

Rights statement

Copyright © 2021 Abu-Raya, Madhi, Omer, Amirthalingam, Giles, Flanagan, Zimmermann, O’Ryan, Safadi, Papaevangelou, Maertens, Wanlapakorn, Diaz-Brito, Tommelein and Esposito. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Repository Status

  • Open

Socio-economic Objectives

Prevention of human diseases and conditions

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC